Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
---|
03/10/2005 | US20050054536 Reacting an cyanoacrylate compound with amidine compound |
03/10/2005 | US20050053678 Methods and compositions for betel nut chewing gum |
03/09/2005 | EP1512397A1 O-substituted hydroxyaryl derivatives |
03/09/2005 | EP1511472A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
03/09/2005 | CN1592618A Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
03/09/2005 | CN1590384A Process for producing a pyran compound |
03/09/2005 | CN1590372A Arylphenyl-substituted cyclic ketoenols |
03/09/2005 | CN1192045C Synthesis of copolymers containing anhydrofructose derivatives |
03/08/2005 | US6864397 E.g., 1-(4-(4-pentylcyclohexyl)cyclohexyldifluoromethoxy)-4 -trifluoromethoxybenzene; preparation from difluorocyclo-hexylidenes, e.g. 1-(4-(trans-4-propylcyclohexyl)cyclohexyl-difluoromethoxy)-3,4,5 -trifluorobenzene; liquid crystals |
03/08/2005 | US6864278 Antifungal agents of sordarin derivatives |
03/03/2005 | WO2005019159A1 OPTICALLY ACTIVE α-AMINOOXYKETONE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF |
03/03/2005 | WO2004101508A3 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
03/03/2005 | US20050049429 Kinase inhibitors; antiproliferative agents; anticancer agents; psoriasis; restenosis |
03/03/2005 | US20050049422 New salts of HMG-CoA reductase inhibitors |
03/03/2005 | US20050049414 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
03/03/2005 | US20050049283 Compounds that inhibit factor xa activity |
03/03/2005 | US20050049280 e.g., ethyl 4-(hydroxyaminocarbonyl)-4-[4-(p-trifluoromethylphenoxy)piperidin-1-ylsulfonyl]piperidine-N-carboxylate |
03/03/2005 | US20050049249 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
03/03/2005 | US20050048315 Such as 4-(dicyanomethylene)-2-{p-(dialkylamino)styryl}-6-{p-(diarylamino)styryl}-4H-pyran; improved carrier transportation and exhibits long wavelength light |
03/03/2005 | DE102004021338A1 New pyran compounds are useful as components in liquid crystalline media, preferably in optoelectronic displays |
03/02/2005 | EP1510515A1 Phenylglycine derivatives as serine protease inhibitors |
03/02/2005 | EP1509495A1 Anilino liver x-receptor modulators |
02/24/2005 | WO2005016277A2 Arylsulfonamidobenzylic compounds |
02/24/2005 | US20050043399 Dimeric compounds and their use as anti-viral agents |
02/24/2005 | US20050043278 administering to a patient a hydroxy compound to treat aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, septicemia and syndrome X |
02/24/2005 | CA2533638A1 Arylsulfonamidobenzylic compounds |
02/23/2005 | EP1508560A2 Substituted Phenylketoenols |
02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
02/23/2005 | CN1585767A Dimeric compounds and their use as anti-viral agents |
02/23/2005 | CN1585766A Dimeric compounds and their use as anti-viral agents |
02/23/2005 | CN1585765A Dimeric compounds and their use as anti-viral agents |
02/23/2005 | CN1585764A Dimeric compounds and their use as anti-viral agents |
02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
02/23/2005 | CN1583737A Synthesis of cinvastatin |
02/23/2005 | CN1583736A Extraction and refinement of lovastatin |
02/22/2005 | US6858749 Process for enantioselectively producing the (R)-delta-lactone |
02/22/2005 | US6858741 Use as pesticides and herbicides |
02/22/2005 | US6858724 Used as anti-tumor agents and/or anti-HIV agents having immunostimulate activities; inversion of OR2 to OR1 in glucopyranose derivtives (R1= H or acetyl, R2= a leaving group such as tosylate, trifluoromesylate or methanesulfonate |
02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
02/17/2005 | WO2005014563A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
02/17/2005 | WO2004067489A8 Hydroxyl compounds and compositions for cholesterol management and related uses |
02/17/2005 | US20050038267 Pyran derivatives containing an exocyclic double bond |
02/17/2005 | US20050038112 prevention, control and treatment of cancer; leukemia |
02/17/2005 | US20050038108 4S, 5R, 6R)-5-Acetylamino-4-azido-6-[(S)-4-nitrophenoxycarbonyloxy)-(2-oxo-[1,3]dioxolan-4R-yl)methyl]- 5,6-dihydro-4H-pyran2-carboxylic acid methylester; modified at the carboxyl or hydroxyl or amino functions; orthomyxovirus and paramyxovirus infections; a long lung residency time and high potency |
02/17/2005 | US20050038106 polyketides; for inhibiting proliferation of lung cancer or leukemia cells |
02/17/2005 | US20050038021 2,4,5,-trisubstituted phenylketo-enols for use as pesticides and herbicides |
02/17/2005 | US20050037289 monomers that can be homopolymerized or copolymerized with other reactive components to make resins within sub-200 nanometer (nm) photoresist compositions |
02/17/2005 | DE102004022891A1 Novel pyran compounds having exocyclic double bonds are useful as components in liquid crystalline media, preferably in optoelectronic displays |
02/17/2005 | CA2534675A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
02/16/2005 | EP1506211A1 C-aryl glucoside sglt2 inhibitors and method |
02/16/2005 | EP1506183A1 Method of forming iron hydroxypyrone compounds |
02/16/2005 | EP1506158A2 Diamino-functional chalcones |
02/16/2005 | EP1506157A2 Amino-functional chalcones |
02/16/2005 | EP1268463B1 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
02/16/2005 | EP1064285B1 Novel cephalotaxane derivatives and process for their preparation |
02/16/2005 | EP0986540B1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers |
02/15/2005 | US6855832 O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
02/14/2005 | WO2005024025A1 Polyene polyketides and methods of production |
02/10/2005 | WO2005012279A1 Lactonization process |
02/10/2005 | WO2005012246A1 Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin |
02/10/2005 | WO2005012228A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
02/10/2005 | WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor |
02/10/2005 | US20050032883 Novel substance fki-1083 and process for producing the same |
02/10/2005 | US20050032853 Intermediates for preparing neuraminidase inhibitor conjugates |
02/10/2005 | US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
02/10/2005 | US20050032772 Compounds useful as reversible inhibitors of cysteine proteases |
02/10/2005 | US20050032176 Modular polyketide synthases with altered activity |
02/09/2005 | EP1505050A1 Bridged carbocyclic compounds and methods of making and using same |
02/09/2005 | EP1124443B1 Solid delivery systems for aroma ingredients |
02/09/2005 | CN1578769A Processes for the manufacturing of 3-hydroxy-n, 1, 6-trialkyl-4-oxo-1, 4-dihydropyridine-2-carboxamide |
02/08/2005 | US6852717 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor; for use in therapy of diseases and pathological conditions involving inflammation such as chronic inflammatory disease |
02/08/2005 | US6852711 HIV protease inhibitors |
02/03/2005 | WO2005009983A1 Method for the detection of nucleophilic chemical species |
02/03/2005 | WO2005009940A1 Novel aminobenzophenone compounds |
02/03/2005 | CA2530302A1 Novel aminobenzophenone compounds |
02/02/2005 | EP1501844A1 Disaccharides for drug discovery |
02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors |
02/02/2005 | EP1501815A1 Substituted phenylacetamides and their use as glucokinase activators |
02/02/2005 | EP1501800A1 Bombesin antagonists |
02/02/2005 | EP1501791A1 Amino acid analogues |
02/02/2005 | EP1501777A1 Direct, enantioselective aldol coupling of aldehydes using chiral organic catalysts |
02/01/2005 | US6849744 3-(substituted phenyl),4-substituted-5H-1,2-oxathiole 2-oxide or 2,2-dioxide compounds useful as agricultural fungicides, insecticides, herbicides |
02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
02/01/2005 | CA2276719C Anilide derivatives and antiarrhythmic agents containing the same |
01/27/2005 | US20050020588 Cysteine protease inhibitors |
01/27/2005 | US20050019278 Block solar radiation; applying to skin, hair |
01/27/2005 | US20050017216 Liquid crystals; using metastasis catalysts; reduction, hydrogenation |
01/26/2005 | EP1500643A1 Benzamide derivatives |
01/26/2005 | EP1499573A1 Homogeneous process for the hydrogenation of carboxylic acids and derivatives thereof |
01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
01/26/2005 | CN1186335C Process for obtaining HMG-CoA reductase inhibitors of high purity |
01/20/2005 | WO2005005432A1 Novel 2,7-dioxo-bicyclo[4.3.0]non-5-yl-urea derivatives |
01/20/2005 | WO2005005406A1 Process for production of 4-aminotetrahydropyrans and salts thereof with acids, intermediates for the process, and process for production thereof |
01/20/2005 | WO2005004810A2 Arylsulfonamide derivatives |
01/20/2005 | WO2004089926A8 Genipin derivatives and uses thereof |
01/19/2005 | EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
01/19/2005 | EP1497247A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
01/19/2005 | EP0777492B1 Combinatorial libraries of substrate-bound cyclic organic compounds |
01/19/2005 | CN1568370A Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
01/19/2005 | CN1185224C Oxidation of ketones to esters using tin substituted zeolite beta |